Private Wealth Management Group, LLC Pacira Bio Sciences, Inc. Transaction History
Private Wealth Management Group, LLC
- $253 Billion
- Q3 2024
A detailed history of Private Wealth Management Group, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 23 shares of PCRX stock, worth $407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 140
83.57%
Holding current value
$407
Previous $4.01 Million
91.34%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
273Shares Held
48.4MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$142 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$90 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$38.3 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$36.6 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$33.7 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $811M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...